COSTEM 2019 | Time to abandon chemotherapy-based mobilization?

Mohamad Mohty

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, provides his opinion on whether it is time to abandon chemotherapy-based approaches to stem cell mobilization – including those in paediatric indications – in place of cytokine-based approaches. This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video